[go: up one dir, main page]

ATE119028T1 - Verwendung von lysin und/oder arginin pyrrolidone-carboxylate als antioxidationsmittel in kosmetika oder pharmazeutika. - Google Patents

Verwendung von lysin und/oder arginin pyrrolidone-carboxylate als antioxidationsmittel in kosmetika oder pharmazeutika.

Info

Publication number
ATE119028T1
ATE119028T1 AT92401189T AT92401189T ATE119028T1 AT E119028 T1 ATE119028 T1 AT E119028T1 AT 92401189 T AT92401189 T AT 92401189T AT 92401189 T AT92401189 T AT 92401189T AT E119028 T1 ATE119028 T1 AT E119028T1
Authority
AT
Austria
Prior art keywords
lysine
pharmaceutics
cosmetics
antioxidants
arginine
Prior art date
Application number
AT92401189T
Other languages
English (en)
Inventor
Guyen Lan Quang N
Etienne Soudant
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE119028T1 publication Critical patent/ATE119028T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT92401189T 1991-04-24 1992-04-24 Verwendung von lysin und/oder arginin pyrrolidone-carboxylate als antioxidationsmittel in kosmetika oder pharmazeutika. ATE119028T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105062A FR2675692A1 (fr) 1991-04-24 1991-04-24 Systeme anti-oxydant contenant du pyrrolidone carboxylate de lysine et/ou du pyrrolidone carboxylate d'arginine soit seul soit associe a un derive phenolique et son utilisation en cosmetique.

Publications (1)

Publication Number Publication Date
ATE119028T1 true ATE119028T1 (de) 1995-03-15

Family

ID=9412210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92401189T ATE119028T1 (de) 1991-04-24 1992-04-24 Verwendung von lysin und/oder arginin pyrrolidone-carboxylate als antioxidationsmittel in kosmetika oder pharmazeutika.

Country Status (10)

Country Link
US (1) US5352695A (de)
EP (1) EP0511118B1 (de)
JP (1) JP3405740B2 (de)
AT (1) ATE119028T1 (de)
AU (1) AU1507692A (de)
CA (1) CA2066924C (de)
DE (1) DE69201510T2 (de)
DK (1) DK0511118T3 (de)
ES (1) ES2069970T3 (de)
FR (1) FR2675692A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
JP3686434B2 (ja) * 1993-10-01 2005-08-24 千寿製薬株式会社 コンタクトレンズ用剤の安定化方法
IT1286564B1 (it) * 1996-03-05 1998-07-15 Comiter Trading & Services S R Un prodotto a base di olio extravergine di oliva,olio vergine di oliva od olio di oliva arricchito ed integrato,ed un procedimento per
FR2746316B1 (fr) * 1996-03-19 1998-06-12 Guerlain Nouvelles compositions cosmetologiques ou dermatologiques
JP3497335B2 (ja) * 1996-11-12 2004-02-16 株式会社資生堂 口紅用組成物
FR2815872A1 (fr) * 2000-10-31 2002-05-03 Sephra Nouvelles compositions cosmetiques et leur utilisation pour diminuer l'adhesion des granulocytes
FR2815866B1 (fr) * 2000-10-31 2015-06-19 Sephra Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6497885B2 (en) 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
CN1326514C (zh) * 2002-05-29 2007-07-18 荷兰联合利华有限公司 含有胺盐的化妆品组合物中气味的控制
FR2840531B1 (fr) * 2002-06-11 2004-10-29 Oreal Composition cosmetique comprenant un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) pour lutter contre la canitie
JP2006512285A (ja) 2002-06-11 2006-04-13 ロレアル 毛包メラノサイトの保護剤としてのドーパクローム異性化酵素（ｔｒｐ−２）活性を真似る薬剤の使用とその使用
US20040185074A1 (en) * 2003-03-17 2004-09-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Odor control in amine salt containing cosmetic compositions
AU2005218539A1 (en) 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
JP5168996B2 (ja) * 2007-04-13 2013-03-27 味の素株式会社 アミノ酸類高配合防腐水溶液
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
FR3040296B1 (fr) * 2015-09-01 2019-06-14 Usines Chimiques D'ivry La Bataille Sa Composition cosmetique et/ou dermatologique comprenant l'acide pyrrolidone carboxylate d'arginine pour lutter contre le vieillissement cutane
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
JP7412898B2 (ja) 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP7612326B2 (ja) 2019-12-16 2025-01-14 ロレアル 特定の成分の組合せを含む安定な組成物
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
FR3131845B1 (fr) 2022-01-19 2024-11-01 Oreal Composition stable comprenant un rétinoïde
WO2023120390A1 (en) 2021-12-20 2023-06-29 L'oreal Stable composition comprising retinoid and ascorbic acid compound
KR20240099313A (ko) 2021-12-20 2024-06-28 로레알 레티노이드를 포함하는 안정한 조성물
WO2024135424A1 (en) 2022-12-20 2024-06-27 L'oreal Composition comprising hyaluronic acid-based polyion complex and hydrophilic or lipophilic antioxidant
FR3145279A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition comprenant un complexe polyionique à base d’acide hyaluronique et un antioxydant lipophile
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid
FR3145278A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition de dispersion stable comprenant un rétinoïde
FR3148912A1 (fr) 2023-05-24 2024-11-29 L'oreal Composition comprenant des polymères cationiques et anioniques
FR3152226A3 (fr) 2023-08-25 2025-02-28 L'oreal Composition cosmétique anhydre pour une application douce et peu grasse

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671020A (en) * 1979-11-15 1981-06-13 Shiseido Co Ltd Cosmetics
JPS6130509A (ja) * 1984-07-23 1986-02-12 Shiseido Co Ltd 皮膚外用剤
IT1202426B (it) * 1987-01-26 1989-02-09 Poli Ind Chimica Spa Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
GB8821129D0 (en) * 1988-09-09 1988-10-12 Unilever Plc Cosmetic composition

Also Published As

Publication number Publication date
DE69201510T2 (de) 1995-07-13
EP0511118A1 (de) 1992-10-28
US5352695A (en) 1994-10-04
AU1507692A (en) 1992-10-29
CA2066924C (fr) 1998-10-20
DE69201510D1 (de) 1995-04-06
FR2675692B1 (de) 1995-01-13
FR2675692A1 (fr) 1992-10-30
CA2066924A1 (fr) 1992-10-25
EP0511118B1 (de) 1995-03-01
JPH05271048A (ja) 1993-10-19
JP3405740B2 (ja) 2003-05-12
ES2069970T3 (es) 1995-05-16
DK0511118T3 (da) 1995-05-01

Similar Documents

Publication Publication Date Title
ATE119028T1 (de) Verwendung von lysin und/oder arginin pyrrolidone-carboxylate als antioxidationsmittel in kosmetika oder pharmazeutika.
DE69030212D1 (de) Verwendung von Derivaten des 4-Phenyl-1,2,3,4-tetrahydro-1-naphthalenamins zur Behandlung von Psychose, Entzündung und als Immununterdrücker
IL87488A0 (en) Pharmaceutical compositions for the topical treatment of conditions associated with photodamaged skin,comprising substituted propenyl phenyl derivatives
ZA924926B (en) Cosmetic composition
ATE145643T1 (de) 1,3,5-triazinderivate, ihre herstellung und ihre verwendung als lichtschutzmittel
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
DE59510219D1 (de) Verwendung von flavonoiden als immunmodulierende oder immunschützende agenzien in kosmetischen und dermatologischen zubereitungen
DK0805853T3 (da) Afstamningsdirigeret induktion af differentiering af humane mesenkyme stamceller
BR9403783A (pt) Uso de uma composição cosmética
AU633714B2 (en) New uses of l-deprenyl and compositions for same
ATE103815T1 (de) Verwendung von thrombospondin zur beschleunigung der wundheilung.
ATE242000T1 (de) Verwendung von sericin als antioxidantien und tyrosinase-inhibitoren
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69023980D1 (de) 2-(RS)-substituierte-2,3-dihydro-5-oxy-4,6,7-trimethyl-benzofurane, verwendbar als antioxydante Arzneimittel mit mukoregulierender und anti-ischemischer Wirkung.
DK0563085T3 (da) Hidtil ukendte præparater
DE59100496D1 (de) Verwendung von selektiv hydrierten Styrol-Butadien-Copolymerisaten in kosmetischen und pharmazeutischen Zubereitungen.
IT1240683B (it) Composizione farmaceutica contenente egf
DE69528820D1 (de) Verwendung von Zahnpflegemitteln enthaltend bovines Kolostrum
DE59101214D1 (de) Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
DE69305230D1 (de) Kosmetisches Mittel
CA2100405A1 (en) Cosmetic skin-care product against ageing of the skin as an effect of light
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
ATE113828T1 (de) Kosmetische zusammensetzung.
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
EP0706786A3 (de) Verwendung von Chlorogensäure als Antioxidans in kosmetischen, insbesondere haarkosmetischen Zubereitungen, sowie Zubereitungen, Chlorogensaüre enthaltend

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties